Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02284953
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
DMH | N4,N4-DIMETHYL-ASPARAGINE | E,F,G,H | 1NKK | 0.71 |  |
| DMH | N4,N4-DIMETHYL-ASPARAGINE | A,B,C,D,E,F, G,H | 1NJT | 0.71 | |
| DMH | N4,N4-DIMETHYL-ASPARAGINE | E,F,G,H | 1NJU | 0.71 | |
| DMH | N4,N4-DIMETHYL-ASPARAGINE | Y,Z | 1JQ7 | 0.71 | |
| DMH | N4,N4-DIMETHYL-ASPARAGINE | C | 1NKM | 0.71 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2E68 | 0.72 | |
| DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 1XGE | 0.72 | |
| DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z29 | 0.72 | |
| DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z26 | 0.72 | |
| DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z27 | 0.72 | |
| DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z28 | 0.72 | |
| DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z2A | 0.72 | |
| DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z24 | 0.72 | |
| DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z25 | 0.72 | |
SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 1OEX | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWX | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVW | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVX | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWW | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 1GKT | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 2OWC | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVV | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVT | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2VS2 | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A | 1OEW | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,I | 1GVU | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2JJJ | 0.73 | |
| SUI | (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID | A,B | 2JJI | 0.73 | |
193 | (2S)-4-(BETA-ALANYLAMINO)-2-AMINOBUTANOIC ACID | A | 1XY5 | 0.7 | |
BUI | (3R)-3-{[(TETRADECYLAMINO)CARBONYL]AMINO}- 4-(TRIMETHYLAMMONIO)BUTANOATE | A | 2FW3 | 0.72 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G65 | 0.7 | |
| SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6A | 0.7 | |
| SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G68 | 0.7 | |
| SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG7 | 0.7 | |
| SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6C | 0.7 | |
| SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG6 | 0.7 | |
C99 | {(2R)-2-[(1S,2R)-1-AMINO-2-HYDROXYPROPYL]- 2-HYDROXY-4,5-DIOXOIMIDAZOLIDIN- 1-YL}ACETIC ACID | A | 2HCG | 0.76 | |
DI6 | 3-[(4S)-2,5-DIOXOIMIDAZOLIDIN-4- YL]PROPANOIC ACID | A | 2Q09 | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,K,L | 1B8D | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1GH0 | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D | 1XF6 | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, H,I,J,K,L,M | 1B33 | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B | 1I7Y | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B | 3BRP | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B | 1JBO | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B | 1ALL | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,K,L | 1EYX | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1HA7 | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D | 2VJH | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B | 1KTP | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B | 1PHN | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D | 1QGW | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D | 1XG0 | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B | 2VJT | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, K,L,M,N,O,P | 2BV8 | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B | 2V8A | 0.71 | |
| MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H | 3DBJ | 0.71 | |
175 | 3,5-DIHYDRO-5-METHYLIDENE-4H-IMIDAZOL- 4-ON | A,B,C,D,E,F, G,H | 1T6P | 0.81 | |
| 175 | 3,5-DIHYDRO-5-METHYLIDENE-4H-IMIDAZOL- 4-ON | A,B | 1T6J | 0.81 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z26 | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 1J79 | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 1XGE | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z29 | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B,G,H | 1R0C | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z27 | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z28 | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z2A | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z24 | 0.71 | |
| NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z25 | 0.71 | |
QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID | A | 1P1O | 0.72 | |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID | A,B | 1S9T | 0.72 | |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID | A,B | 1MM6 | 0.72 | |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID | A | 2JBK | 0.72 | |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID | A,B,C,D,E,F | 2AL4 | 0.72 | |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID | A,B,C | 1MM7 | 0.72 | |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID | A | 3B6T | 0.72 | |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID | A | 2OR4 | 0.72 | |
6PR | (S)-4-AMINO-4-OXO-3-(2-PHOSPHONOACETAMIDO)BUTANOIC ACID | A,B,C,D | 2H3E | 0.72 | |